These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 1554054)

  • 1. Spouses' assessments of Alzheimer patients' response to THA and lecithin.
    Fitten LJ; Ganzell S
    Am J Psychiatry; 1992 Apr; 149(4):575. PubMed ID: 1554054
    [No Abstract]   [Full Text] [Related]  

  • 2. Delayed matching-to-sample performance during a double-blind trial of tacrine (THA) and lecithin in patients with Alzheimer's disease.
    Perryman KM; Fitten LJ
    Life Sci; 1993; 53(6):479-86. PubMed ID: 8341134
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of Alzheimer's disease with short- and long-term oral THA and lecithin: a double-blind study.
    Fitten LJ; Perryman KM; Gross PL; Fine H; Cummins J; Marshall C
    Am J Psychiatry; 1990 Feb; 147(2):239-42. PubMed ID: 2405720
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tacrine (tetrahydroaminoacridine; THA) and lecithin in senile dementia of the Alzheimer type: a multicentre trial. Groupe Français d'Etude de la Tetrahydroaminoacridine.
    Chatellier G; Lacomblez L
    BMJ; 1990 Feb; 300(6723):495-9. PubMed ID: 2107926
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of tacrine and lecithin in Alzheimer's disease. A population pharmacodynamic analysis of five clinical trials.
    Holford NH; Peace K
    Eur J Clin Pharmacol; 1994; 47(1):17-23. PubMed ID: 7988619
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tetrahydroaminoacridine and lecithin for Alzheimer's disease.
    N Engl J Med; 1990 Sep; 323(13):919-20. PubMed ID: 2395447
    [No Abstract]   [Full Text] [Related]  

  • 7. An enriched-population, double-blind, placebo-controlled, crossover study of tacrine and lecithin in Alzheimer's disease. The Tacrine 970-6 Study Group.
    Foster NL; Petersen RC; Gracon SI; Lewis K
    Dementia; 1996; 7(5):260-6. PubMed ID: 8872417
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tacrine treatment of Alzheimer's disease: many expectations, few certainties.
    Malaguarnera M; Pistone G; Vinci M; Motta M; di Fazio I; Rampello L
    Neuropsychobiology; 1998 Nov; 38(4):226-31. PubMed ID: 9813462
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tetrahydroaminoacridine and lecithin in the treatment of Alzheimer's disease. Effect on cognition, functioning in daily life, behavioural disturbances and burden experienced by the carers.
    Weinstein HC; Teunisse S; van Gool WA
    J Neurol; 1991 Feb; 238(1):34-8. PubMed ID: 2030370
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of tacrine and lecithin in mild to moderate Alzheimer's disease: double blind trial.
    Maltby N; Broe GA; Creasey H; Jorm AF; Christensen H; Brooks WS
    BMJ; 1994 Apr; 308(6933):879-83. PubMed ID: 8173365
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tetrahydroaminoacridine-lecithin combination treatment in patients with intermediate-stage Alzheimer's disease. Results of a Canadian double-blind, crossover, multicenter study.
    Gauthier S; Bouchard R; Lamontagne A; Bailey P; Bergman H; Ratner J; Tesfaye Y; Saint-Martin M; Bacher Y; Carrier L
    N Engl J Med; 1990 May; 322(18):1272-6. PubMed ID: 2183056
    [TBL] [Abstract][Full Text] [Related]  

  • 12. What have we learned from the THA trials to facilitate testing of new AChE inhibitors.
    Gauthier S; Gauthier L
    Prog Brain Res; 1993; 98():427-9. PubMed ID: 8248532
    [No Abstract]   [Full Text] [Related]  

  • 13. Are drugs targeted at Alzheimer's disease useful? 1. Useful for what?
    Levy R
    BMJ; 1990 Apr; 300(6732):1131-2. PubMed ID: 2344540
    [No Abstract]   [Full Text] [Related]  

  • 14. Tacrine in Alzheimer's disease.
    Eagger SA; Levy R; Sahakian BJ
    Lancet; 1991 Apr; 337(8748):989-92. PubMed ID: 1673209
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Canadian collaborative study of tetrahydroaminoacridine (THA) and lecithin treatment of Alzheimer's disease: effect on mood.
    Vida S; Gauthier L; Gauthier S
    Can J Psychiatry; 1989 Apr; 34(3):165-70. PubMed ID: 2655861
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Progress report on the Canadian Multicentre Trial of tetrahydroaminoacridine with lecithin in Alzheimer's disease.
    Gauthier S; Bouchard R; Bacher Y; Bailey P; Bergman H; Carrier L; Charbonneau R; Clarfield M; Collier B; Dastoor D
    Can J Neurol Sci; 1989 Nov; 16(4 Suppl):543-6. PubMed ID: 2680009
    [TBL] [Abstract][Full Text] [Related]  

  • 17. SPECT brain imaging in Alzheimer's disease during treatment with oral tetrahydroaminoacridine and lecithin.
    Cohen MB; Fitten LJ; Lake RR; Perryman KM; Graham LS; Sevrin R
    Clin Nucl Med; 1992 Apr; 17(4):312-5. PubMed ID: 1572123
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oral tetrahydroaminoacridine treatment of Alzheimer's disease evaluated clinically and by regional cerebral blood flow and EEG.
    Minthon L; Gustafson L; Dalfelt G; Hagberg B; Nilsson K; Risberg J; Rosén I; Seiving B; Wendt PE
    Dementia; 1993; 4(1):32-42. PubMed ID: 8358504
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Piracetam plus lecithin trials in senile dementia of the Alzheimer type.
    Samorajski T; Vroulis GA; Smith RC
    Ann N Y Acad Sci; 1985; 444():478-81. PubMed ID: 3893273
    [No Abstract]   [Full Text] [Related]  

  • 20. [Comparison of tacrine hepatotoxicity in patients with Alzheimer disease or AIDS].
    Fredj G; Dietlin F; Barbier G; Jasmin C; Bonhomme L; Esctein S; Misset JL; Meyer P; Kalifa D; Beugre T
    Therapie; 1992; 47(3):245-7. PubMed ID: 1295125
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.